Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PepsiCo (PEP) downgraded to Sell from Neutral at Goldman Sachs with analyst Judy Hong saying the potential for continued softer North American Beverage volumes could weigh on the company's organic sales growth. 2. Bristol-Myers (BMY) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying the Opdivo + Yervoy combination showed worse efficacy cross-trial compared to Merck's (MRK) Keytruda+chemo combo. 3. Acacia (ACIA) downgraded to Neutral from Buy at BofA/Merrill and to Neutral from Overweight at Piper Jaffray. 4. International Paper (IP) downgraded to Sector Perform from Outperform at RBC Capital with analyst Paul Quinn saying the company has "considerable tailwinds" in its core North America containerboard business, as well as strong conditions in the pulp and paper business, but sees the potential acquisition of Smurfit Kappa (SMFTF) clouding the picture while producing a "considerable valuation overhang." 5. WWE (WWE) downgraded to Neutral from Overweight at JPMorgan with analyst David Karnovsky saying he views the stock's current risk/reward as more balanced ahead of the company's media rights cycle. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER - Macatawa... To see the rest of the story go to thefly.com. See Story Here